Sponsors (4)
The resolution raises awareness and highlights research and policy needs around brain tumors—potentially prompting future funding or action—but is symbolic and does not itself provide funding or change clinical care, so immediate patient outcomes are unlikely to improve.
People with brain tumors (including children) will have greater public awareness and recognition because May 2025 is designated National Brain Tumor Awareness Month, which can improve early recognition, public support, and reduce stigma.
The resolution highlights research gaps and the need for basic research, which may encourage researchers, funders, and private initiatives to pursue more studies toward better treatments and understanding of brain tumors.
Calling attention to the scale of diagnoses, deaths, and prevalence informs policymakers and the public, increasing the likelihood of future policy attention, funding requests, or social-service responses for people affected by brain tumors.
People with brain tumors will not receive immediate improvements in care or funding because the designation is largely symbolic and does not allocate resources or change clinical practice.
Raising awareness without matching increases in research funding or treatment access may create public and patient expectations for new therapies that may not materialize, leading to frustration or disappointment.
Based on analysis of 2 sections of legislative text.
Designates May 2025 as National Brain Tumor Awareness Month and highlights incidence, mortality, survival, research gaps, and the need for awareness and research support.
Introduced May 1, 2025 by Michael T. McCaul · Last progress May 1, 2025
Recognizes May 2025 as National Brain Tumor Awareness Month and records findings about the incidence, prevalence, survival, mortality, research gaps, and need for public awareness and research. The text cites estimates of over 93,000 brain tumor diagnoses in 2025 (including about 5,000 children), roughly 90,000 diagnoses in 2024, more than 1,000,000 Americans living with a brain tumor, and about 18,330 deaths in 2025. It notes a 35.7% five-year survival rate for primary malignant brain tumors, limited approved treatments and early detection tools, and little improvement in mortality over the prior 30 years, and highlights the need for increased awareness and research support.